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SUMMARY 
Research background. From ancient times plants have been used for medicinal purpos-
es against various ailments. In the modern era, plants are a major source of drugs and are 
an appealing drug candidate for the anticancer therapeutics against various molecular 
targets. Here we tested methanolic extract of dry leaves of Tamarix articulata for antican-
cer activity against a panel of hepatocellular carcinoma cells.
Experimental approach. Cell viability of hepatocellular carcinoma cells was determined 
by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay after a 
dose-dependent treatment with the extract of T. articulata. Phase-contrast microscopy 
and 4’,6-diamidino-2-phenylindole (DAPI) staining served to analyse cellular and nuclear 
morphology. Immunoblotting was performed to determine the expression of proteins 
associated with autophagy, apoptosis and cell cycle. However, flow cytometry was used 
for the quantification of apoptotic cells and the analysis of cells in different phases of the 
cycle after the treatment with various doses of T. articulata. Additionally, acridine orange 
staining and 2’,7’-dichlorofluorescein diacetate (DCFH-DA) dye were used to analyse the 
quantification of autophagosomes and reactive oxygen species. 
Results and conclusion. Our results demonstrate that T. articulata methanolic extract 
exhibits promising antiproliferative activity with IC50 values (271.1±4.4), (298.3±7.1) and 
(336.7±6.1) µg/mL against hepatocellular carcinoma HepG2, Huh7D12 and Hep3B cell lines, 
respectively. Mechanistically, we found that T. articulata methanolic extract induces cell 
death by activating apoptosis and autophagy pathways. First, T. articulata methanolic ex-
tract promoted autophagy, which was confirmed by acridine orange staining. The immu-
noblotting analysis further confirmed that the extract at higher doses consistently induced 
the conversion of LC3I to LC3II form with a gradual decrease in the expression of auto-
phagy substrate protein p62. Second, T. articulata methanolic extract promoted reactive 
oxygen species production in hepatocellular carcinoma cells and activated reactive oxy-
gen species-mediated apoptosis. Flow cytometry and immunoblotting analysis showed 
that the plant methanolic extract induced dose-dependent apoptosis and activated 
proapoptotic proteins caspase-3 and PARP1. Additionally, the extract triggered the arrest 
of the G0/G1 phase of the cell cycle and upregulated the protein expression of p27/Kip and 
p21/Cip, with a decrease in cyclin D1 expression in hepatocellular carcinoma cells. 
Novelty and scientific contribution. The current study demonstrates that T. articulata 
methanolic extract exhibits promising anticancer potential to kill tumour cells by pro-
grammed cell death type I and II mechanisms and could be explored for potential drug 
candidate molecules to curtail cancer in the future. 
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INTRODUCTION
Hepatocellular carcinoma (HCC) is the predominant primary cancer in most countries 
and seventh most frequent cancer across the globe (1). HCC is the second most lethal can-
cer-associated mortality in the world, with an annual rate of around 1.2 million deaths, 
mainly in the under-developing and developing countries of East Asia and Africa (2). The 
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incidence of HCC varies according to gender, age, ethnicity 
and geographical distribution. The majority (more than 80 %) 
of HCC cases occur in African and East Asian countries, with 
an incidence rate of more than 20 people in 100 000 individ-
uals. HCC rarely appears below the age of 40 and males are 
at higher risk than females (3). Several etiological factors that 
have a casual association with HCC are chronic viral infections 
such as hepatitis B virus (HBV) or hepatitis C virus (HCV), fre-
quent exposure to aflatoxin B1, liver cirrhosis due to alcohol 
abuse, and non-alcoholic fatty liver (4). Patients with early 
disease are often asymptomatic and consequently diagnosed 
at a late stage when the disease is untreatable (5).
At the molecular level, HCC is complex and heterogene-
ous due to several key mutations. These mutations cause ab-
errant modulations of key proteins that result in the deregu-
lation of crucial signalling pathways (6,7). Owing to many 
genetic mutations in the HCC and the deregulation of many 
signalling pathways, HCC is often resistant to the current reg-
iment of therapeutic modalities (8). The therapeutic options 
are surgical resection and are often more successful if the ma-
lignancy is diagnosed at an early stage of the disease (9). Al-
though liver transplantation is the best effective therapeutic 
approach to deal with HCC; only around 5 % of patients can 
benefit from this approach because of histocompatibility and 
organ availability issues (10). Except transplantation, other 
therapeutic options are chemotherapy and radiotherapy. Re-
grettably, HCC resists most cytotoxic drugs. Among chemo-
therapeutic drugs, sorafenib, a kinase inhibitor, is the drug of 
choice against HCC and increases patient’s survival time for 
only a few months (11).
For the last two decades, various novel synthetic chemo-
therapeutic drugs have been used in clinical settings to treat 
cancer, but still not much success has been achieved due to 
considerable cost of development and off-target deleterious 
effects on normal cells, which causes serious adverse effects 
like gastrointestinal upset, suppression of immune system, 
and the development of drug resistance, thereby leading to 
failure of these drugs (12). Thus, identification and evaluation 
of plant-based novel extracts or compounds are seemingly 
important.
Natural products obtained from the plant kingdom have 
received great attention for promising chemotherapeutic po-
tential and are the prime source of medicines for other ail-
ments. Owing to their structural complexity, natural products 
can hit multiple targets at various stages of tumourigenesis 
and associated inflammation (13). This provides evidence that 
natural products are promising anticancer molecules to tar-
get deregulated signalling pathways at multiple sites to cur-
tail cancer. More than 60 % of anticancer drugs come from 
plant-based natural products or their derivatives (14). At pres-
ent, around 3000 plants across the globe have been reported 
to have anticancer potential. Globally, around 10 to 40 % of 
plant-derived products are used for the treatment of cancer 
and they are expected to reach 50 % in Asia (15). Therefore, 
there is a continuous demand for search and development 
of novel and effective drugs from natural sources (plant 
sources) which specifically kill tumour cells with fewer unde-
sirable effects against normal cells.
Plant-based extracts or natural compounds derived from 
plant extracts with chemopreventive activity are a vital 
source of drugs against many diseases including cancer (16). 
Approximately more than 50 % of the current regiment of the 
Food and Drug Administration (FDA)-approved drugs are de-
rived from plants (17). Yet, there are numerous plants of vari-
ous species that could have the potential to exhibit pharma-
cological activities and can be an important source of novel 
compounds for future therapeutics with great efficacy 
against tumour cells and fewer toxicity issues against normal 
human cells. Intending to search for novel compounds with 
less deleterious effects, we focused on natural medicines. 
One of the plants from the deserts of Saudi Arabia containing 
a variety of secondary metabolites that could be used for the 
production of anticancer therapeutics is Tamarix articulata 
(18). The plant belongs to the family Tamaricaceae and is a 
halophytic plant growing in extremely harsh and arid condi-
tions. Traditionally, the plant is used to treat various ailments 
such as gastrointestinal, skin and heart diseases and other 
ailments (19). However, recent evidence suggests that owing 
to the presence of various polyphenolic compounds, T. artic-
ulata exhibits some promising pharmacological activities 
such as antioxidant, antidiabetic, hypolipidemic, antibacteri-
al and hepatoprotective activities (20–24). The major chemical 
constituents of the T. articulata dry leaf extract are quinic acid, 
gallic acid, kaempferol, quercetin, tamarixetin, epicatechin 
gallate and epiafzelechin. These phytochemicals are respon-
sible for pharmacological properties including antioxidant, 
antibacterial, anticancer, antidiabetics and hepatoprotective 
activities (18). Crude extracts of the plants in other parts of 
the world have been reported to exhibit anticancer activities 
by inhibiting cell viability in various types of cancer cells (17). 
Our recent study (21) reveals that methanolic extracts of all T. 
articulata parts (root, stem, dry and fresh leaves) collected 
from the Qassim region of Saudi Arabia have promising anti-
oxidant activity due to the presence of polyphenolic and fla-
vonoid compounds. Additionally, we documented that all 
methanolic extracts of different plant parts exhibit potential 
anticancer effect; however, the data were preliminary and 
without any mechanistic study. Therefore, in the current 
study, we evaluated the antiproliferative activity of the meth-
anolic extract of dry leaves of T. articulata against a panel of 
HCC cells (HepG2, Hep3B and Huh7D12) in an attempt to bet-
ter understand the underlying anticancer mechanism. We ob-
served that the plant methanolic extract simultaneously in-
duces apoptosis and autophagy in HCC (Hep2G) cells. 
Additionally, the plant methanolic extract triggered the ar-
rest of the G0/G1 phase of the cell cycle and increased the pro-
tein expression of cyclin-dependent kinase inhibitor 1B (p27/
Kip), encoded by the CDKN1B gene and cyclin-dependent ki-
nase inhibitor 1 (p21/Cip), encoded by the CDKN1A gene, with 
a decrease in the expression of cyclin D1 in Hep2G cells. To-
gether, these results proved that T. articulata medicinal plant 
can be explored as a potential drug candidate to curtail can-
cer in near future. 
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MATERIALS AND METHODS
Collection of plant material and extract preparation
The plant material (leaves of Tamarix articulata) was col-
lected in August 2019 from desert regions of Qassim province 
of the Kingdom of Saudi Arabia. The leaves were air dried in 
the shade to remove moisture. The methanolic extract of dry 
leaves was prepared as per the standard protocol mentioned 
in our previous publication (21). 
Cell culture and treatments
Hepatocellular carcinoma (HCC) cells (HepG2, Hep3B and 
Huh7D12) and normal transformed cells THLE-2 were pro-
cured from the American Type Culture Collection (ATCC; 
Manassas, VA, USA). All the procured cell lines were cultured 
in the required medium (minimum essential medium; Ther-
mo Fisher Scientific, Waltham, MA, USA) and maintained un-
der sterile conditions at 37 °C in a 5 % CO2 incubator (New 
Brunswick Scientific, Maldon, UK). Penicillin-streptomycin 
(pen-strep, 1 %; Thermo Fisher Scientific) and 10 % foetal bo-
vine serum from Gibco (Dublin, Ireland) were added to the 
growth medium to supply essential growth factors for the 
proper growth of the cells. The cells were periodically evalu-
ated for mycoplasma contamination.
Preparation of plant stock solution
The stock solution of 10 mg/mL dry leaf methanolic ex-
tract was made in dimethyl sulfoxide aliquoted and stored at 
–20 °C in sterile microcentrifuge (1.5 mL) tubes. At the time of 
experiment, stock concentration was diluted serially in cul-
ture medium to obtain the working concentration in a range 
of 10–10 000 µg/mL for the treatment of HCC (HepG2, Hep3B 
and Huh7D12) cells. 
Chemicals and antibodies
Propidium iodide, rapamycin, camptothecin, 3-(4,5-di-
methylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT), 
hydrogen peroxide, 4’,6-diamidino-2-phenylindole (DAPI), 
staurosporine, 2’,7’-dichlorofluorescein diacetate (DCFH-DA), 
dimethyl sulphoxide (DMSO), FITC-conjugated annexin V, 
acridine orange, Tris-buffered saline with 0.1 % Tween® 20 
detergent and N-acetylcysteine came from Sigma-Aldrich, 
Merck (St. Louis, MO, USA). The required primary antibodies 
(cyclin D1, β-actin, p27, p21, MAPLC3I/II, SQSTM1/P62, PARP1 
and caspase-3) were from Cell Signaling Technology (Leiden, 
The Netherlands). The enzyme-labelled mouse and rabbit IgG 
secondary antibodies were procured from Santa Cruz Bio-
technology (Dallas, TX, USA). 
Cell proliferation/viability assay
The cell viability was determined by the most commonly 
used MTT assay as per the standard protocol (25). After 
trypsinization of HCC cells (HepG2, Hep3B, Huh7 and THLE-2) 
from the primary cell culture flask, the cells were uniformly 
suspended in culture medium and distributed in 96-well 
plate at a density of 2·103 cells per well. After overnight incu-
bation, the cells were exposed to various doses of plant meth-
anolic extract and DMSO control for 24 h. The plated cells 
were flooded with 20 µL of 2.5 mg/mL MTT dye solution at 
37 °C for 3–4 h. The MTT dye interacts with succinyl dehydro-
genase of live mitochondria to form formazan crystals. The 
purple colour formation developed after dissolving the for-
mazan crystals in DMSO. Subsequently, the absorbance of the 
coloured solution was measured at 570 nm with the help of 
the multi-plate reader. The number of viable cells was ana-
lysed by GraphPad Prism v. 5.0 software (26) to calculate the 
percentage of cell proliferation of the treated group com-
pared to the DMSO control group. 
Apoptosis detection using flow cytometry
Annexin V-FITC apoptosis detection kit was employed to 
analyse apoptosis using flow cytometry (27). In brief, 5·105 
HCC (HepG2) cells were harvested and plated in each well of 
the 6-well plate and allowed to adhere to the surface prop-
erly overnight. The cells were exposed to various doses of 
plant methanolic extract in the presence of untreated control 
for 24 h under sterile conditions at 37 °C and 5 % CO2. Next, 
the cells were harvested, washed with ice-cold phos-
phate-buffered saline (PBS) 3 times, and resuspended in 
binding buffer solution followed by the addition of 5 µL each 
of FITC-conjugated annexin V and propidium iodide for 10–15 
min at 4 °C in the dark. After that, incubation samples were 
analysed using flow cytometry (BD FACS CaliburTM; BD Biosci-
ence, Franklin Lakes, NJ, USA) to quantify the apoptotic cell 
population. 
Cell cycle analysis
Briefly, 5·105 HepG2 cells were harvested and plated in 
each well of the 6-well plate and allowed to adhere properly 
(28). The cells were exposed to various concentrations (125, 
250 and 500 mg/mL) of the plant methanolic extract and un-
treated control at 37 °C in a 5 % CO2 incubator for 24 h. The 
treated cells were harvested, washed and fixed in 70 % ice- 
-cold ethanol overnight at 4 °C. The next day, the cells were 
processed for cell cycle analysis by incubation with RNase 
(100 μg/mL) for 30 min at 37 °C and stained with propidium 
iodide (50 μg/mL) in the dark for another 30 min at 4 °C. The 
cell cycle analysis was done by using the BDTM LSRII flow cy-
tometry system (BD Bioscience) to analyse cells in different 
phases of their cycle. 
Phase-contrast microscopy
HCC (HepG2) cells (5·105) were seeded on coverslips in 
30-mm Petri dishes and were exposed to different con-
centrations of plant methanolic extract for 24 h (29). After 
completion of the treatment, the cells were processed for 
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phase-contrast microscope LSM-510 (Carl Zeiss, Munich, Ger-
many) to detect the phenotypic changes in the morphology 
of the treated cells. 
Immunoblotting
Briefly, 0.5·106 HepG2 cells were harvested and seeded in 
each well of the 6-well plate overnight to adhere properly as 
per the standard protocol (16). The plated HCC (HepG2) cells 
were treated with different doses of plant methanolic extract 
(125, 250 and 500 mg/mL) and control DMSO for 24 h. After 
the treatment, the cells were harvested, washed with PBS and 
resuspended in cell lysis buffer. The resuspended cells were 
constantly vortexed for 10 s and the solution was kept in ice 
for at least 2 min, and the step was repeated at least five 
times. The obtained cell lysis solution was subjected to cen-
trifugation (12 000×g; 5810 R; Eppendorf, Chennai, India) at 
4 °C for 10 min. The obtained supernatant was collected in 
separate autoclaved microtubes, followed by protein estima-
tion using standard Bradford method (30). An equal amount 
of protein sample (30 µg) obtained from various treatments 
was loaded in each well of pre-cast SDS-PAGE gel and the gel 
was allowed to resolve based on molecular mass at a stand-
ard voltage and current. Properly resolved proteins of the 
SDS-PAGE gel were transferred onto the polyvinylidene flu-
oride (PVDF) membrane (Millipore, Darmstadt, Germany) in-
cubated with a 5 % blocking solution containing fat-free milk 
in Tris-buffered saline with 0.1 % Tween® 20 detergent (TBST) 
to block non-specific antigen-binding sites. The PVDF mem-
brane was incubated with the primary antibody at the de-
sired dilution at room temperature for 3–4 h or overnight at 
4 °C to ensure proper binding with respective protein/anti-
gen. After the completion of incubation, the PVDF membrane 
was gently washed with TBST at least five times and was 
again probed with enzyme-tagged IgG secondary antibody 
for 1 h at 37 °C. The membrane was again gently washed with 
TBST at least five times. The membrane was flooded and 
incubated in enhanced chemiluminescence plus substance 
to spot the presence of the protein with the help of x-ray film or 
with ChemiDoc imaging system (Bio-Rad, Hercules, CA, USA). 
Reactive oxygen species activity determination
Reactive oxygen species (ROS) activity was determined 
by commonly used DCFH-DA dye which is oxidised to green, 
fluorescent dichlorofluorescein (DCF) as per the standard 
protocol (31). Briefly, 105 HCC (HepG2) cells were harvested 
after trypsinization and plated in each well of a 6-well plate 
overnight to attach to the surface properly. The plated cells 
were exposed to various doses of plant methanolic extract in 
the presence and absence of N-acetylcysteine (5 mM) (Sig-
ma-Aldrich, Merck), untreated control and positive control 
(H2O2) at 37 °C for 24 h. The treated cells in each well were gen-
tly washed with ice-cold PBS and incubated with DCFH-DA 
dye for 30 min at 37 °C in a 5 % CO2 incubator (New Brun-
swickTM S41i; Eppendorf) for staining. Subsequently, stained 
cells were photographed under a fluorescent microscope 
(Eclipse E600; Nikon, Tokyo, Japan) and the plates were ana-
lysed by a fluorescence microplate reader (Infinite F50; Tecan, 
Männedorf, Switzerland) at 488 nm excitation and 525 nm 
emission wavelengths. 
Autophagosome staining
The detection of autophagosomes by microscopy was 
done according to standard protocol (31). Briefly, 105 HCC 
(HepG2) cells were harvested after trypsinization and plated 
in each well of a 6-well plate overnight to attach to the sur-
face properly. The plated cells were exposed to various doses 
(125, 250 and 500 µg/mL) of plant methanolic extract, un-
treated control, and positive control (rapamycin, c=100 nM) 
at 37 °C for 24 h. Next, the cells containing plant methanolic 
extract in culture medium were removed and fresh medium 
containing acridine orange (1 mg/mL) was added and incu-
bated for 15 min at 37 °C in 5 % CO2. The plated acridine or-
ange-stained cells were analysed under a fluorescent micro-
scope. They were bright red due to low or acidic pH in the 
autophagosomes. Cells from many fields were counted until 
100 cells were reached to determine the percentage of cells 
with promoted autophagosome formation. 
Nuclear morphology determination by DAPI staining
Nuclear morphology was analysed by 4’,6-diamidi-
no-2-phenylindole (DAPI) staining (32). Briefly, 5·104 HCC 
(HepG2) cells were seeded and plated in the 8-well chamber 
slide and allowed to adhere properly to the surface of the 
chamber slide. Next morning, HCC (HepG2) cells were treated 
with different doses of plant methanolic extract, untreated 
control, and positive control (camptothecin, c=2 µM) for 24 h. 
Cells were rinsed with cooled PBS, followed by fixing and per-
meabilisation with 4 % paraformaldehyde and Triton X-100, 
respectively. Finally, the fixed cells were mounted with Ultra-
cruz mounting medium and were analysed by a LSM-510 mi-
croscope (Carl Zeiss) for the detection of nuclear morphology. 
Statistical analysis
All the experimentations were executed (N=3). The statis-
tical analysis of all experiments was performed using Graph-
Pad Prism software (26) from three independent experi-
ments. All the obtained results represent the mean value ± 
standard error of the mean (SEM), calculated and processed 
by one-way ANOVA. The p-value equal to or less than 0.05 
was considered significant. 
RESULTS AND DISCUSSION
The current study demonstrated for the first time that the 
methanolic extract of Tamarix articulata dry leaves exhibits 
cytotoxic potential and promotes simultaneous induction of 
autophagy and apoptosis in HCC (HepG2) cells. A mechanistic 
study reveals that upon treatment with various doses of the 
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plant methanolic extract, HCC (HepG2) cells augment auto-
phagic cell death by promoting the formation of autophago-
somes, which were analysed by acridine orange staining. Fur-
thermore, the immunoblotting demonstrates the steady 
conversion of microtubule-associated protein 1A/1B-light 
chain 3-I (LC3I) to microtubule-associated protein 1A/1B-light 
chain 3-II (LC3II) with gradual degradation of sequestosome-1 
(SQSTM1/p62) upon treatment with various doses of the plant 
extract. Moreover, we observed a significant induction of ap-
optosis, which was supported by activation of apoptosis 
marker proteins caspase-3 and PARP1 at higher doses of the 
plant methanolic extract. DAPI staining, phase contrast mi-
croscopy and elevated levels of ROS further confirmed the 
cell killing by apoptosis. Additionally, the plant methanolic 
extract triggered cell cycle arrest at the G0/G1 phase and in-
creased the expression of cell cycle checkpoint proteins p27/
Kip and p21/Cip with a decrease in the expression of cyclin 
D1 in the cells treated with various doses of the plant meth-
anolic extract (Fig. 1). Together these results suggest that the 
medicinal plant T. articulata can be explored as a potential 
drug candidate to curtail cancer in the future. 
Previous reports demonstrated that numerous plant ex-
tracts exhibit an antiproliferative potential against a wide 
range of cellular models of cancer (33,34). T. articulata meth-
anolic extract reveals several pharmacological properties like 
anti-inflammatory, hepatoprotective, antioxidative and anti-
proliferative activity by modulating miR-1275 in hepatocellu-
lar carcinoma cells (18,20). Thus, we sought to examine the in 
vitro inhibitory activity of the plant methanolic extract 
against the HCC cell (HepG2, Huh7, Hep3B and THLE-2) pro-
liferation. We observe that the plant methanolic extract start-
ed attenuation of growth kinetics of HCC (HepG2, Huh7, 
Hep3B and THLE-2) cells at an incredibly low dose of 10 µg/mL. 
It was observed that the IC50 value was (271.0±4.4), (298.0±7.1) 
and (336.0±6.1) µg/mL against HepG2, Huh7D12 and Hep3B 
cell lines, respectively (Fig. 2 and Table 1). Interestingly, when 
the inhibitory effect on the growth of transformed normal 
THLE-2 cells was evaluated, we observed that 50 % popula-
tion of the cells died at (3641.0±23.7 µg/mL) of the plant 
methanolic extract (Fig. 2 and Table 1), which is a significant-
ly high dose of the plant methanolic extract compared to IC50 
dose against HCC (HepG2, Huh7, Hep3B and THLE-2) cells. This 
indicates that the plant methanolic extract not only curtails 
the cellular growth kinetics of HCC cells specifically, but also 
displays safe cytotoxicity potential against normal cells. To-
gether, our results suggest that the methanolic extract of dry 
leaves of halophytic T. articulata plant displays potential cy-
totoxic effect against a panel of HCC cells and leaving normal 
transformed liver cells with weaker cytotoxic effect.  
Fig. 1. The schematic diagram of the methanolic extract of Tamarix articulata dry leaves exerts the antiproliferative effect by simultaneous induc-
tion of cell death by two biologically conserved processes: autophagy by the conversion of LC3I to LC3II followed by the degradation of SQSTM1/
P62 and apoptosis that is associated with the activation of casapase-3 and PARP1 cleavage in HepG2 cells. Furthermore, the methanolic extract 
of dry leaves triggers cell cycle arrest at G0/G1 phase by upregulating the regulatory proteins p27/Kip and p21/Cip with concomitant reduction in 
cyclin D1 in HCC cells. ROS=reactive oxygen species
Fig. 1
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Table 1. IC50 value of the methanolic extract of Tamarix articulata dry 
leaves against a panel of hepatocellular carcinoma cells (HepG2, Huh-






Data are presented as the mean value±standard error (S.E.), N≥3, 
p<0.05
Next, the microscopic analysis indicated that a substantial 
number of dead, floating tumour cells were observed at high-
er doses of the plant methanolic extract than untreated con-
trol (Fig. 3a), indicating that the percentage of cell death in 
groups treated with the plant extract was significantly high-
er than with the DMSO control. Furthermore, cell killing by 
the plant methanolic extract was also confirmed by the nu-
clear morphology of DAPI stain, which revealed the change 
in the membrane blebbing and nuclear morphology, which 
are the hallmarks of apoptosis (Fig. 3b). The above results 
demonstrate that the plant methanolic extract induces a po-
tent antiproliferative effect on the cellular models of HCC 
(HepG2, Huh7, Hep3B and THLE-2).
Badmus et al. (35) suggested that Holarrhena floribunda 
extract displayed an antiproliferative activity against tumour 
cells and triggered cell cycle arrest by inducing ROS-mediat-
ed apoptosis induction. Similarly, Kowalczyk et al. (36) showed 
that Menyanthes trifoliata L. extract significantly inhibited the 
growth of glioma cells by attenuating the expression of an-
ti-apoptotic proteins, triggered arrest of the G2/M phase of 
cell cycle, activated mitochondrion-dependent apoptosis 
and augmented the expression of apoptosis proteins Bax and 
caspase-3. Various studies have revealed that natural com-
pounds obtained from plants have a promising apoptosis-in-
ducing ability in cancer cells (37–39). Mechanistically, apop-
tosis induced by natural compounds disrupts the association 
of antiapoptotic protein Bcl-2 from the proapoptotic proteins, 
thereby activating a cascade of proapoptotic proteins (40). 
Plant-based extracts and derived compounds have been 
documented to activate cell death mechanisms by activating 
cellular caspases, promote intrinsic apoptosis by releasing cy-
tochrome C, induce ROS production and activation of 5’ 
adenosine monophosphate-activated protein kinase (AMPK) 
which ultimately leads to activation of cell death mechanisms 
in tumour cells (41,42). Thus, we wanted to evaluate the ap-
optotic potential of T. articulata methanolic extract against 
HCC (HepG2) cells. Therefore, we exposed HepG2 cells to dif-
ferent doses of the plant methanolic extract for 24 h and un-
treated control. With flow cytometry, we observed that a sub-
stantial cellular population of HepG2 cells underwent 
apoptosis (23.1 %) at a higher dose of the plant methanolic 
extract (500 μg/mL) than with positive control staurosporine 
(25 nM) (42.1 %) (Fig. 4a and Fig. 4b). To further confirm the 
activation of apoptosis, we performed immunoblotting anal-
ysis of HepG2 cells treated with the plant methanolic extract 
in a concentration-dependent manner (125, 250 and 500 µg/
mL). Our results suggest that higher concentrations of the 
plant methanolic extract activate apoptosis-promoting pro-
teins by inducing prominent cleavage of caspase-3 and 
PARP1 when compared to untreated control (Fig. 4c). 
ROS and associated peroxidases play a key role in the reg-
ulation of cell death in multiple cancer cell types. Accumulat-
ed evidence revealed that elevation of ROS by natural 
c(staurosporine)=25 nMγ(extract)=500 µg/mLγ(extract)=250 µg/mL
γ(extract)=125 µg/mLControl
100 µm
100 µm100 µm100 µm
100 µm
a)
c(camptothecin)=2 μMγ(extract)=500 µg/mLγ(extract)=250 µg/mL
γ(extract)=125 µg/mLControl
50 µm
50 µm50 µm50 µm
50 µm
b)
Fig. 2. Antiproliferative effect of methanolic extract of Tamarix artic-
ulata dry leaves against hepatocellular carcinoma cells (HepG2, Huh- 
-7D12 and Hep3B, and transformed cell line THLE-2), confirmed by 
the MTT assay. Data are presented as the mean value±standard error 
(S.E.), N≥3, *p<0.05 
Fig. 3. Induction of HepG2 cell death by methanolic extract of Tam-
arix articulata dry leaves: a) HepG2 cells treated with various concen-
trations of the extract, positive control (c(staurosporine)=25 nM) and 
untreated control (DMSO). The images were taken by a microscope 
inbuilt with a camera; scale bar: 100 µm, magnification: 20×, and b) 
images of 4’,6-diamidino-2-phenylindole (DAPI) stained cells after 
treatment with the extract, positive control (c(camptothecin)=2 µM) 
and untreated control (DMSO). Scale bar: 50 µm, magnification: 20×. 
DMSO=dimethyl sulphoxide 
Fig. 2 Fig. 3
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products is the major driver of the activation of cancer cell 
death pathways. In the recent past, reports have suggested 
that chemotherapeutic agents induce apoptotic cell death 
by elevating ROS production (31). To examine whether the 
plant methanolic extract could also induce ROS production 
in HepG2 cells, we exposed HepG2 cells to various doses of 
the plant extract in the presence of ROS activator H2O2 (posi-
tive control, 100 μM) or untreated control for 24 h and stained 
the cells with DCFH-DA dye after the treatment. DCFH-DA dye 
easily passes through the membrane by diffusion and is 
deacetylated with cellular esterases to non-fluorescent com-
pound. The non-fluorescent compound is then oxidised to 
produce green colour compound 2’,7’-dichlorofluorescein in 
the presence of ROS. Intriguingly, we observed that the plant 
extract promotes significant ROS production in a concentra-
tion-dependent manner as compared to untreated control. 
However, HepG2 cells exposed to positive control (H2O2, 
100 μM) significantly promoted ROS production (Fig. 5). To-
gether, these results demonstrate that the plant methanolic 
extract activates apoptosis-mediated proteins and promotes 
ROS production, which might have a critical role in the aug-
mentation of apoptosis. 
Autophagy is one of the important catabolic physiologi-
cal processes that help clear the old and damaged cellular 
contents, recycle metabolites with the help of lysosomes and 
utilize them during energy crisis. It plays a dual role in cancer 
therapy and tumourigenesis. Accumulating evidence sug-
gests that most natural products that exhibit antiproliferative 
activity induce autophagic cell death mode in tumour cells 
(31). A previous report revealed that in hepatocellular carci-
noma cells, berberine suppresses hepatocellular carcinoma 
cells by inducing simultaneously mitochondrion-mediated 
apoptosis and autophagic cell death (43). Numerous reports 
suggest that plant-based natural compounds and extracts 
induce autophagy and kill tumour cells by various cell death 
mechanisms (44,45). Therefore, we sought to reveal whether 
T. articulata methanolic extract treatment could augment the 
induction of autophagy in HepG2 cells. To evaluate the effect 
of T. articulata methanolic extract, the HepG2 cells were plat-
ed overnight and exposed to various doses of the plant ex-
tract (Fig. 6a). After the completion of 24-hour incubation, the 
cells were stained with acridine orange. It is observable in Fig. 
6b and Fig. 6c that although majority of the cells exposed to 
lower doses of the plant methanolic extract could not pro-
mote autophagy significantly and displayed acidic vesicular 
Fig. 4. Induction of apoptosis in HepG2 cells by methanolic extract of Tamarix articulata dry leaves: a) quantification of the apoptotic population 
by flow cytometry of HepG2 cells after 24-hour treatment with different concentrations of the extract, positive control (c(staurosporine)=25 nM) 
and untreated control (DMSO); Q1 represents necrotic cell population, Q2 represents early apoptotic cell population, Q3 represents normal cells, 
whereas Q4 represents late apoptotic cell population, b) percentage of apoptotic HepG2 cells in the above-mentioned experiment. Data are 
expressed as the mean value±S.E., N≥3, **p<0.01, and c) protein expression of apoptosis-activated proteins (total caspase-3, cleaved caspase-3, 
total PARP1, cleaved PARP1, and β-actin as an internal control) of HepG2 cells after 24-hour treatment with different concentrations of the extract, 
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Fig. 5. Induction of ROS production in HepG2 cells by methanolic extract of Tamarix articulata dry leaves: a) fluorescent images of 2’,7’-dichlorofluo-
rescein diacetate (DCFH-DA) stained cells after 24-hour treatment with different concentrations of the extract, positive control (H2O2) and untreated 
control (DMSO). Scale bar: 100 µm, magnification 20×, and b) the fluorescence intensity of DCF cells treated with the extract, positive control (H2O2) 
and untreated control (DMSO). Data are expressed as the mean value±S.E., N≥3, *p<0.05. DMSO=dimethyl sulphoxide, DCF=dichlorofluorescein
Fig. 6. Induction of autophagy in HepG2 cells by methanolic extract of Tamarix articulata dry leaves: a) fluorescent images of the acidic vesicular 
formation or autophagosome formation stained by acridine orange (γ=1 mg/mL) after a 24-hour treatment with different concentrations of the 
extract, positive control (c(rapamycin)=100 nM) and untreated control (DMSO). Scale bar: 100 µm, magnification: 20×, b) percentage of acridine 
orange-stained HCC cells upon treatment with different concentrations of the extract, positive control (c(rapamycin)=100 nM) and untreated 
control (DMSO). Data are expressed as the mean value±S.E., N≥3, *p<0.05, and c) expression of the conversion of autophagy proteins LC3I to LC3II 
and expression of p62/SQSTMI and β-actin (internal control) in HCC cells after 24-hour treatment with different concentrations of the extract, 
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organelles (AVOs) in the cytoplasm, cells exposed to higher 
doses of the extract significantly induced AVOs, which appear 
bright red in the cytoplasm of HepG2 cells. Furthermore, im-
munoblotting of HepG2 cells at higher doses of the plant 
methanolic extract revealed a prominent conversion of LC3I 
to LC3II which indicates the maturation of autophagosome 
and induction of autophagy (Fig. 6c). To further evaluate the 
effect of the plant methanolic extract on the flux of auto-
phagy in HepG2 cells, we observed the reduced expression 
with the low band intensity of sequestrosome 1 (P62) protein, 
which is a specific substrate of autophagy, at higher doses of 
the plant methanolic extract than at lower doses. Collective-
ly, these results suggest that HepG2 cells exposed to the plant 
methanolic extract stimulate autophagic flux and augment 
cell death in tumour cells. 
Accumulating evidence suggests that numerous phyto-
chemicals derived from natural sources have been reported 
to exhibit antiproliferative activity by triggering cell cycle ar-
rest, thereby promoting cell death via apoptosis (45,46). Tu-
mour cell proliferation is primarily controlled by the cell cycle 
(46), which consists of four distinct progressive phases 
(subG1/G0, G1, S and G2/M) (47). Under normal circumstances, 
the progression of the cell cycle is tightly regulated by an ac-
tivation cascade of cyclins, cyclin-dependent kinases (CDKs), 
and CDK inhibitors. However, in malignant cells, aberrant 
expression of cell cycle regulators attenuates the differentia-
tion of cells that results in irregular cell growth. In the recent 
past, numerous reports have suggested that natural com-
pounds have antiproliferative activity by triggering cell cycle 
arrest (48). Luo et al. (49) demonstrated that 6-gingerol (6-G) 
enhances the radiosensitivity of gastric cancer cells by the in-
duction of apoptosis and cell cycle arrest. Additionally, Lin et 
al. (50) revealed that 6-G suppresses cell motility of colon can-
cer cells by inducing ROS, and upregulates p21/Cip and p27/
Kip, thereby arresting cell cycle in colon cancer cells (50). To 
examine whether T. articulata methanolic extract could arrest 
the cell cycle, HepG2 cells were synchronised in a low se-
rum-containing medium, and then advanced through vari-
ous cell cycle phases in a serum-containing medium for at 
least 3 h. The cells were then treated with various doses (125, 
250 and 500 µg/mL) of the plant methanolic extract for 24 h. 
Our results demonstrated that T. articulata methanolic extract 
arrested the cell cycle at G0/G1 phase in HepG2 cells. The 
quantification of cells at various cell cycle phases showed that 
a significant growth of cells (18.1 %) was halted at the G0/G1 
phase of the cell cycle when HepG2 cells were exposed to 500 
µg/mL of plant extract as compared to untreated control 
(3.6 %) and positive control 2 µM camptothecin (25.4 %) (Fig. 
7a and Fig. 7b). Next, we sought to examine the effect of the 
plant methanolic extract in the cell cycle regulatory proteins. 
Fig. 7. Induction of cell cycle arrest in G0/G1 phase by methanolic extract of Tamarix articulata dry leaves and modulation of regulatory proteins in 
HepG2 cells: a) quantification of cells in different stages of the cell cycle by flow cytometry after 24-hour treatment of HepG2 cells with different 
concentrations of the extract, positive control (c(camptothecin)=2 μM) and untreated control (DMSO), b) quantification of G0/G1 phase cell cycle 
arrest in HepG2 cells after 24-hour treatment with different concentrations of the extract, positive control (c(camptothecin)=2 µM) and untreated 
control (DMSO). Data are expressed as the mean value±S.E., N≥3, *p<0.05, and c) expression profile of cell cycle regulation proteins (cyclin D1, 
p21/Cip1 and p27/Kip1) in immunoblotting analysis of HepG2 cells exposed to different concentrations of the extract, using β-actin as an internal 
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Our immunoblotting results demonstrate a drastic reduction 
in cyclin D1 expression and a subsequent increase in the ex-
pression of p21/cip1 and p27/Kip1 proteins when HepG2 cells 
were exposed to higher doses of the plant methanolic extract 
(Fig. 7c). Collectively these results demonstrate that the plant 
methanolic extract induced G0/G1 phase cell cycle arrest and 
increased the expression of cell cycle checkpoint proteins 
p27/Kip1 and p21/Cip1 with a concomitant decrease in the 
expression of cyclin D1 in HepG2 cells. 
CONCLUSIONS
Our results document for the first time that the metha-
nolic extract of dry leaves of Tamarix articulata exhibits cyto-
toxic activity and simultaneous activation of two cell death- 
-associated processes in HepG2 cells: apoptosis and auto-
phagy. Mechanistically, T. articulata induced autophagy, 
which was confirmed by prominent orange red colour of 
acidic autophagosomes and steady conversion of LC3I to 
LC3II with gradual degradation of SQSTM1/p62. Furthermore, 
the plant methanolic extract induced ROS-mediated apop-
tosis, which was confirmed by the activation of apoptosis 
marker proteins caspase-3 and PARP1. Additionally, the plant 
methanolic extract triggered the arrest of the G0/G1 phase in 
the cell cycle and increased the expression of cell cycle check-
point proteins p27/Kip and p21/Cip with a decrease in the ex-
pression of cyclin D1 in the cells treated with various doses of 
plant methanolic extract. Collectively, these results prove 
that the medicinal plant T. articulata can be evaluated further 
as a prospective drug candidate compound to inhibit cancer. 
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